BRKR Bruker Corporation
BRKR Bruker Corporation
Healthcare · Medical Devices
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 bull converging
POC $57.61 · VWAP $48.86 · +17.9% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster VP, President sold $312.8K, Aug 18
Coverage
1 watchlist
BRKR Price Structure
Loading timeframes…
Peers
Every watchlist BRKR belongs to, members best 30-day change first — BRKR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-06-30: revenue $839M, diluted EPS -$0.41, net income -$52M (SEC filing). Across the print the stock moved -18.4% (close before → first close after).
full note →Against street estimates
How BRKR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about BRKR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 36 days ago · Sep 17
BRKR research tape
70 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.